Yair Sapir

Yair is a senior Biotech executive with extensive experience in drug development and has served as Biond’s COO since its inception. He has more than 15 years of experience in managing and conducting translational research with a wide knowhow in development of first-in-class antibodies for the treatment of cancer and autoimmune diseases. He was Director of Development and played a critical role in the success of cCAM Biotherapeutics where he oversaw the development of its lead agent. Yair holds a Ph.D. in immunology and an MBA from the Technion – Israel Institute of Technology.